Recombinant Rabbit Anti-PIM2 Antibody (clone R04-5D8) (CAT#: VS3-FY1143)
This product is a recombinant rabbit antibody that recognizes PIM2. This antibody has been reported for use in Western Blot, Immunoprecipitation. The clone R04-5D8 is specific for human PIM2. The antigen is synthetic peptide of human pim2.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Subcellular Location
RNA Expression
Figure 1 IF staining of human cell line U-251 MG
(Immunofluorescent staining of human cell line U-251 MG shows localization to cytosol.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/285/25_H1_1_selected.jpg
(Immunofluorescent staining of human cell line U-251 MG shows localization to cytosol.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/285/25_H1_1_selected.jpg
Figure 2 RNA cell line category: Group enriched (HDLM-2, Karpas-707, RPMI-8226, U-266/70, U-266/84)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000102096-PIM2
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000102096-PIM2
Specifications
- Immunogen
- Synthetic peptide of human PIM2.
- Host Species
- Rabbit
- Type
- Rabbit IgG
- Specificity
- Human PIM2
- Species Reactivity
- Human
- Clone
- R04-5D8
- Applications
- Western Blot, Immunoprecipitation
- Conjugate
- Unconjugated
- MW
- Calculated MW: 34 kDa; Observed MW: 40,38,34 kDa
Product Property
- Purification
- Affinity Purified
- Purity
- >95% as determined by SDS-PAGE
- Buffer
- 50 mM Tris-Glycine, pH 7.4, 0.15 M NaCl, 40% glycerol, 0.05% BSA
- Preservative
- 0.01% Sodium azide
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- Western Blot: 1/500-1/1000
Immunoprecipitation: 1/20
Target
- Alternative Names
- Pim-2 Proto-Oncogene, Serine/Threonine Kinase; Pim-2 Oncogene; EC 2.7.11.1; Pim-2h; Proto-Oncogene Pim-2 (Serine Threonine Kinase); Serine/Threonine-Protein Kinase Pim-2
- Gene ID
- 11040
- UniProt ID
- Q9P1W9
Recommended Products
Secondary Antibody
Isotype Control
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "PIM2"
Select a product category from the dropdown menu below to view related products.
Please select product type
Rabbit Monoclonal Antibody Products
IgG Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-2714 | Hi-Affi™ Recombinant Rabbit Anti-PIM2 Monoclonal Antibody (DS2714AB) | WB, ICC, IP | IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS3-FY1143. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application:
-3.png)
Application: ELISA, FC, Block, SPR
Application: ELISA, FC, WB, FuncS
Application: ELISA, WB, Neut, Funcs, IHC, Inhib
Application: ELISA
-5.jpg)
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, FC, IHC, IF, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
